Advertisement
Advertisement
U.S. markets open in 3 hours 21 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
20.86+0.02 (+0.10%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close20.84
Open20.75
Bid0.00 x 900
Ask0.00 x 1000
Day's Range20.00 - 21.69
52 Week Range6.00 - 59.00
Volume29,418
Avg. Volume125,652
Market Cap270.494M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RGC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Regencell Bioscience Holdings L
    CNK: Lowering target price to $14.00CINEMARK HOLDINGS INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Simply Wall St.

    Do Institutions Own Regencell Bioscience Holdings Limited (NASDAQ:RGC) Shares?

    The big shareholder groups in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) have power over the company...

  • The Independent

    Cineworld to pay £122m to dissenting shareholders after Regal takeover

    The original acquisition of Regal was a deal worth around £2.7 billion, or around 23 US dollars per share, in 2017.

  • Reuters

    UPDATE 1-Cineworld pays $170 mln to Regal investors unhappy with 2017 buyout

    Cineworld, the world's second-largest movie theatre operator, said it will pay $170 million to Regal Entertainment shareholders, who were disgruntled with the price they received when the London-listed company took over the U.S. chain in 2017. According to an agreement, $92 million will be held in escrow and be available to Cineworld as additional liquidity under certain circumstances for the payment, Cineworld said on Friday. Cineworld included $244.2 million in its last annual report, which it said represented the amount payable to a group of Regal's former stakeholders who had challenged whether they received a fair market price for their shares.

Advertisement
Advertisement